Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative Nausea

NCT00445055 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Nausea
Vomiting

Interventions

DRUG: Droperidol

Sponsor

University Hospital, Bordeaux

Collaborators

[object Object]